Galecto, Inc.
SEC Filing List
GLTO CIK: 0001800315
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| 3 | Initial statement of beneficial ownershi... | Burkavage Brian | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/08/2026 | |
| 8-K | Current report filing | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| ARS | Annual report to security holders | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/01/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/29/2026 | |
| DEF 14A | Definitive proxy statements | Damora Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/29/2026 | |
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |||
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/23/2026 | |||
| No record found. | |||||
| Load More | |||||
